Adaptin Bio (APTN) Shares Outstanding (Diluted Average) (2022 - 2026)

Adaptin Bio's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 49.34% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $8.7 million (up 49.34% YoY), while the FY2025 annual figure was $7.8 million, up 140.38% from the prior year.
• Shares Outstanding (Diluted Average) came in at $8.7 million for Q1 2026 at Adaptin Bio, up from $7.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $8.7 million in Q1 2026 to a low of $3.2 million in Q1 2024.
• A 5-year average of $5.4 million and a median of $5.0 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 35.0% in 2024 and surged 140.38% in 2025, its largest moves.
• Adaptin Bio's Shares Outstanding (Diluted Average) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then slumped by 35.0% to $3.2 million in 2024, then surged by 140.38% to $7.8 million in 2025, then increased by 11.39% to $8.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $8.7 million, $7.8 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison